planning, delivery pietro.mancosu@humanitas.it Index AAPM - - PowerPoint PPT Presentation

planning delivery
SMART_READER_LITE
LIVE PREVIEW

planning, delivery pietro.mancosu@humanitas.it Index AAPM - - PowerPoint PPT Presentation

SBRT: prescription, planning, delivery pietro.mancosu@humanitas.it Index AAPM recommendation Monet Rouen cathedral, 1893/94 Italian SBRT-WG Same Gray? Multiplanning experiences Output Factor Take home messages AAPM 101 Recommendations


slide-1
SLIDE 1

pietro.mancosu@humanitas.it

SBRT: prescription, planning, delivery

slide-2
SLIDE 2

Index

AAPM recommendation Italian SBRT-WG Same Gray? Multiplanning experiences Output Factor Take home messages

Monet –Rouen cathedral, 1893/94

slide-3
SLIDE 3

Simulation imaging: Precise delineation of patient anatomy, targets…… CT + MR + PET/CT Scan length: at least 5-10 cm superior and inferior.. CT slice thickness: 1-3 mm. 4DCT or breath-hold techiniques. Treatment planning: ICRU 50 and 62 definitions for GTV, CTV, PTV and OAR. Use of multiple non overlapping beams: … IMRT, VMAT. 6 MV photon beam…beam penetration and penombra 5 mm MLC leaf width is adequate for most applications.

AAPM 101 Recommendations

slide-4
SLIDE 4

Calculation grid size and algorithm: Use of an isotropic grid of 2 mm o finer. Use of convolution/superposition algorithms. No Pencil Beam! Patient positioning, immobilization: Body frames and fiducial systems, abdominal compression… Image guided localization: ..Epid, 3D kV CBCT, ultrasound ecc. Respiratory motion management. Normalization/Prescribing Dose: Various options are available: Isocenter , %IDL: 80%, 65%, 60%, 50%, PTV periphery …

AAPM 101 Reccomendations

slide-5
SLIDE 5

Italy of the towers

San Giminiano 1300 d.C. 72 towers 2000 abitants

slide-6
SLIDE 6

>90 physicists

AIFM SBRT WG

2013-2020

Objective 1:

Sharing of personal knowledge

Objective 2:

Scientific studies and write scientific papers

Objective 3:

Seminars and schools

SABRIphys II – Stereotectic Ablative Body Radiotherapy Italian physicist working group

slide-7
SLIDE 7

Scientific publications

21 papers (2015-2019): 3 letters to the editor; 5 reviews; 13 full papers 6 papers in preparation/under review Best paper EJMP 2017 Focus session EJMP: Physics of lung SBRT(2018)

slide-8
SLIDE 8

Courses

NEW: Basis of SBRT for physicists AIFM/Caldirola March 2020

slide-9
SLIDE 9

Introduction: why knowledge sharing?

https://twitter.com/BreastDocUK/status/805672034239913986?s=08 Dec 5, 2016

#RadOnc

slide-10
SLIDE 10

Do we have the same Gray?

slide-11
SLIDE 11

Multicenter planning: liver

2016 12 centers; 5 liver cases Common protocol 75 Gy – 25Gy x 3 fr V95%>95% (at least 67%)

Best paper EJMP

slide-12
SLIDE 12

Multicenter planning: prostate

2015

14 centers 5 prostate cases Same contours Common protocol 35 Gy – 7Gy x 5 fr

slide-13
SLIDE 13

Multicenter planning: prostate

Mean DVH values over the 5 patients for the 14 centers

slide-14
SLIDE 14

Multicenter planning: prostate

Replanned based on the mean values

slide-15
SLIDE 15

Multicenter plans

2019 submitted

slide-16
SLIDE 16

To be or not to be homogeneous?

2017

slide-17
SLIDE 17

2017

To be or not to be homogeneous?

slide-18
SLIDE 18

Italian Study German Study Prescription 54 Gy in 3 fr 45 Gy in 3 fr Normaliz Not defined V95%>95% 65% isodose (i.e. min dose=45Gy) Dmax Not defined 69.2 Gy PTV-D98% 52.4Gy±4.2% 45.6Gy±5.5% PTV-D50% 56.8Gy±6.0% 56.6Gy±4.2%

To be or not to be homogeneous?

2017

slide-19
SLIDE 19

2017

To be or not to be homogeneous?

slide-20
SLIDE 20

ICRU 83

50 Gy prescribed to mean PTV volume PTV Dmax = 53-55Gy Dmean = 50 Gy Dmin = 47.5-48Gy HI = 7-10%

AAPM report 101

50 Gy prescribed to periphery PTV (80%) PTV Dmax = 62.5 Gy Dmean = 54-57 Gy Dmin = 50 Gy HI = 20%

GammaKnife style

50 Gy prescribed to periphery CTV (50%)

PTV?

CTV Dmax = 100 Gy Dmean = 70-80 Gy Dmin = 50 Gy HI = 50%

ICRU91 - Where to normalize the dose

slide-21
SLIDE 21

ICRU 91

slide-22
SLIDE 22

ICRU 91

slide-23
SLIDE 23

ICRU 91

50 Gy prescribed to NO INDICATION

Report of : D98% D50% D2%

Vilfredo Pareto Criterion 1 Criterion 2 PTV: maximize Dmin OAR: reduce Dmax PTV: minimize Dmax PTV: maximize Dmean PTV: minimize Dmax Body: reduce D50%

ICRU91 - Where to normalize the dose

Multicriteria problem

slide-24
SLIDE 24

ICRU91 - Where to normalize the dose

Multiplanning SBRT lung study 28 centers involved

140 plans

Mancosu, ESTRO 2013 Gradient index: PTVmin/BodyD50

  • Hom. index: (PTVmin-PTVmax)/PTVmean

Open questions:

Density dishomogeneity Target motion (…)

slide-25
SLIDE 25

Multiplanning: spinal metastases

2019

43 TPS from 38 centers Crowd knowledge sharing

slide-26
SLIDE 26

Spinal metastases - Materials

2019

Prescription dose (PD): 30Gy in 3 fractions. Planning objective: >90% of the PTV with PD; >80% minor violation. Planning constraints (from AAPM 101): PRV cord: V18Gy<0.35cm3, V21.9 Gy<0.03cm3; Heart: V24Gy<15cm3,V30Gy<0.03cm3; Esophagus: V17.7 Gy<5cm3, V25.2 Gy<0.03cm3; Stomach: V16.5 Gy<10cm3, V22.2 Gy<0.03cm3; Bowel: V16.5 Gy<5cm3; V25.2 Gy<0.03cm3. As a last option, planners were allowed to decrease the prescription dose to 27Gy to fulfill all OAR constraints.

slide-27
SLIDE 27

Spinal metastases - Results

2019

In the first analysis, 12.5%of plans (12/96) failed to meet the minimum protocol requirements Ten of 12 plans were successfully re-optimized using the information coming from more skilful planners

SPINE 2

0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 VMAT VMAT FFF Cyberknife Tomotherapy IMRT 3dCRT

QI

Quality index parameter: (D98%-PTV/ D0.03cm3 x PRV midollo)*1/nC.I.

slide-28
SLIDE 28

Power is nothing without control

slide-29
SLIDE 29

Ongoing project

https://sbrtvirtualaudit.it/

slide-30
SLIDE 30
  • L. Rossi et al. Acta Oncol. 2018

How good is a SBRT plan?

slide-31
SLIDE 31

10 patients

How good is a SBRT plan?

  • L. Rossi et al. Acta Oncol. 2018
slide-32
SLIDE 32

MANplan/clinical AUTOplan

Prostate SBRT

slide-33
SLIDE 33

Small and Big

slide-34
SLIDE 34

New imaging possibilities

slide-35
SLIDE 35

Lateral charged particle loss

Small fields

0% 5% 10% 15% 1 2 3 5 7 10

Size (cm)

fase 1 fase 2

0.200 0.300 0.400 0.500 0.600 0.700 0.800 0.900 1.000 1 2 3 4 5 6 7 8 9 10

Output Factor Size (cm)

27 centers Output factor (5-100mm) Square fields with jaws Phase 1: Own detector Phase 2: Common detector (diamond) 2016

Trigeminal neuralgia size

slide-36
SLIDE 36

Small fields

0% 5% 10% 15% 1 2 3 5 7 10

Size (cm)

fase 1 fase 2

slide-37
SLIDE 37

Small fields: universal curve?

curve

slide-38
SLIDE 38

Small fields: universal curve?

8 TrueBeam 10 FFF 2400 MU/min Output Factor: 6-50mm Nominal Field Size (NFS) Effective field Size (EFS)

10 mm ± 1mm (i.e. up to 20% differences) 100 mm ± 1mm (i.e. <<1% differences) Jaws intrinsic geometric uncertainty

2016

slide-39
SLIDE 39

Small fields: universal curve?

2016 Nominal Field Size (NFS) Effective field Size (EFS)

slide-40
SLIDE 40

Small fields: universal curve?

2018

slide-41
SLIDE 41

Take home message: Sharing of knowledge

2016 Best paper 2016 2018 2014 Letter

slide-42
SLIDE 42

Discussion time